Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of "First-Line" Rhythm Therapy on AF Progression

NCT05514860 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of "First-Line" Rhythm Therapy on AF Progression
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2017
Completion date
November 30, 2022
Enrollment
303 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.